Aviva T. Horowitz
- Biomaterials top 0.5%
- Molecular Biology top 5%
- Biomedical Engineering top 5%
- Oncology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Alberto GabizónDorit GorenSamuel ZalipskyDinah TzemachDina TzemachTali SiegalAlberto GabizonHilary Shmeeda
- Topics
- Nanoparticle-Based Drug Delivery (13 papers)RNA Interference and Gene Delivery (6 papers)Glycosylation and Glycoproteins Research (4 papers)
- Partner nations
- IsraelUnited StatesSpain
In The Last Decade
Aviva T. Horowitz
29 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 110
- Biomaterials 1.5k
- Molecular Biology 1.3k
- Biomedical Engineering 719
- Oncology 514
- Radiology, Nuclear Medicine and Imaging 270
Countries citing papers authored by Aviva T. Horowitz
This map shows the geographic impact of Aviva T. Horowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aviva T. Horowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aviva T. Horowitz more than expected).
Fields of papers citing papers by Aviva T. Horowitz
This network shows the impact of papers produced by Aviva T. Horowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aviva T. Horowitz. The network helps show where Aviva T. Horowitz may publish in the future.
Co-authorship network of co-authors of Aviva T. Horowitz
This figure shows the co-authorship network connecting the top 25 collaborators of Aviva T. Horowitz. A scholar is included among the top collaborators of Aviva T. Horowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aviva T. Horowitz. Aviva T. Horowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 49 | |
| 2 | 175 | |
| 3 | Folate receptor targeting of pegylated liposomal cisplatin enhances anti-tumor activity in mouse models without increasing toxicity | 2 |
| 4 | 128 | |
| 5 | Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. | 332 |
| 6 | 120 | |
| 7 | Diagnostic value of AgNOR staining in thyroid cytology. | 7 |
| 8 | Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model. | 60 |
| 9 | 190 | |
| 10 | 81 | |
| 11 | 146 | |
| 12 | 190 | |
| 13 | 25 | |
| 14 | 125 | |
| 15 | 10 | |
| 16 | 23 | |
| 17 | 10 | |
| 18 | 8 | |
| 19 | 31 | |
| 20 | 2 |
About Aviva T. Horowitz
Aviva T. Horowitz is a scholar working on Biomaterials, Oncology and Urology, having authored 29 papers that have together received 2.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (13 papers), RNA Interference and Gene Delivery (6 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Biomaterials (1.5k citations), Pharmaceutical Science (134 citations) and Molecular Biology (1.3k citations). Aviva T. Horowitz has collaborated with scholars based in Israel, United States and Spain. Frequent co-authors include Alberto Gabizón, Dorit Goren, Samuel Zalipsky, Dinah Tzemach, Dina Tzemach, Tali Siegal, Alberto Gabizon, Hilary Shmeeda, Frederika Mandelbaum-Shavit and Dan Gibson. Their work appears in journals such as Nature, Cancer and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.